Assessment of Mycobacterium tuberculosis transmission in Oxfordshire, UK, 2007–12, with whole pathogen genome sequences: an observational study  by Walker, Timothy M et al.
www.thelancet.com/respiratory   Vol 2   April 2014 285
Articles
Assessment of Mycobacterium tuberculosis transmission in 
Oxfordshire, UK, 2007–12, with whole pathogen genome 
sequences: an observational study
Timothy M Walker, Maeve K Lalor, Agnieszka Broda, Luisa Saldana Ortega, Marcus Morgan, Lynne Parker, Sheila Churchill, Karen Bennett, 
Tanya Golubchik, Adam P Giess, Carlos Del Ojo Elias, Katie J Jeﬀ ery, Ian C J W Bowler, Ian F Laurenson, Anne Barrett, Francis Drobniewski, Noel D McCarthy, 
Laura F Anderson, Ibrahim Abubakar, H Lucy Thomas, Philip Monk, E Grace Smith, A Sarah Walker, Derrick W Crook, Tim E A Peto*, Christopher P Conlon* 
Summary 
Background Patients born outside the UK have contributed to a 20% rise in the UK’s tuberculosis incidence since 2000, 
but their eﬀ ect on domestic transmission is not known. Here we use whole-genome sequencing to investigate the 
epidemiology of tuberculosis transmission in an unselected population over 6 years. 
Methods We identiﬁ ed all residents with Oxfordshire postcodes with a Mycobacterium tuberculosis culture or a clinical 
diagnosis of tuberculosis between Jan 1, 2007, and Dec 31, 2012, using local databases and checking against the national 
Enhanced Tuberculosis Surveillance database. We used Illumina technology to sequence all available M tuberculosis 
cultures from identiﬁ ed cases. Sequences were clustered by genetic relatedness and compared retrospectively with 
contact investigations.  The ﬁ rst patient diagnosed in each cluster was deﬁ ned as the index case, with links to subsequent 
cases assigned ﬁ rst by use of any epidemiological linkage, then by genetic distance, and then by timing of diagnosis.
Findings Although we identiﬁ ed 384 patients with a diagnosis of tuberculosis, country of birth was known for 380 and we 
sequenced isolates from 247 of 269 cases with culture-conﬁ rmed disease. 39 cases were genomically linked within 
13 clusters, implying 26 local transmission events. Only 11 of 26 possible transmissions had been previously identiﬁ ed 
through contact tracing. Of seven genomically conﬁ rmed household clusters, ﬁ ve contained additional genomic links to 
epidemiologically unidentiﬁ ed non-household members. 255 (67%) patients were born in a country with high tuberculosis 
incidence, conferring a local incidence of 109 cases per 100 000 population per year in Oxfordshire, compared with 3·5 cases 
per 100 000 per year for those born in low-incidence countries. However, patients born in the low-incidence countries, 
predominantly UK, were more likely to have pulmonary disease (adjusted odds ratio 1·8 [95% CI 1·2–2·9]; p=0·009), social 
risk factors (4·4 [2·0–9·4]; p<0·0001), and be part of a local transmission cluster (4·8 [1·6–14·8]; p=0·006).
Interpretation Although inward migration has contributed to the overall tuberculosis incidence, our ﬁ ndings suggest that 
most patients born in high-incidence countries reactivate latent infection acquired abroad and are not involved in local 
onward transmission. Systematic screening of new entrants could further improve tuberculosis control, but it is 
important that health care remains accessible to all individuals, especially high-risk groups, if tuberculosis control is not 
to be jeopardised.
Funding UK Clinical Research Collaboration (Wellcome Trust, Medical Research Council, National Institute for Health 
Research [NIHR]), and NIHR Oxford Biomedical Research Centre. 
Copyright © Walker et al. Open Access article distributed under the terms of CC BY. 
Introduction
The burden of tuberculosis in the UK is among the highest 
in western Europe, with about 9000 new cases per year.1 
The incidence has risen by more than 20% since 2000, 
from 11·4 to 13·9 cases per 100 000 population.2 Although 
the additional cases are accounted for by patients who 
were born overseas,3 the role of these patients in local 
transmission remains unclear. Designing control 
measures to reverse the increase in incidence requires an 
improved understanding of the contributions of reactivated 
versus newly acquired infections to overall disease. 
The UK National Strain Typing Project introduced 
routine 24-locus mycobacterial interspersed repetitive unit-
variable number tandem repeats (MIRU-VNTR) geno-
typing in 2010,4 but this method cannot be used to reliably 
distinguish recent from past transmission.5 The results of 
several studies have shown the additional resolution 
provided by use of whole-genome sequencing (WGS) of 
Mycobacterium tuberculosis in outbreak settings,5–7 but this 
technique has yet to be applied to study an unselected, 
geographically restricted population. Oxfordshire (popu-
lation 760 000) is a low-incidence region (8·4 cases 
per 100 000 population) where, like the UK as a whole, most 
cases are restricted to a small number of urban areas.2,8 
Here we use WGS to investigate the incidence of tuber-
culosis arising from transmission in Oxfordshire and 
whether transmission varies between people born in high-
incidence versus low-incidence settings.
Lancet Respir Med 2014  
2: 285–92
Published Online
March 4, 2014
http://dx.doi.org/10.1016/
S2213-2600(14)70027-X
See Comment page 251
*Contributed equally
Nuﬃ  eld Department of 
Medicine, University of Oxford, 
Oxford, UK (T M Walker MRCP, 
T Golubchik PhD, A P Giess MSc, 
C Del Ojo Elias MSc, 
A S Walker PhD, 
Prof D W Crook FRCPath, 
Prof T E A Peto FRCP, 
C P Conlon FRCP); Department 
of Microbiology and Infectious 
Disease, Oxford University 
Hospitals NHS Trust, Oxford, 
UK (T M Walker, M Morgan MSc, 
K J Jeﬀ ery FRCPath, 
I C J W Bowler FRCPath, 
Prof D W Crook, Prof T E A Peto, 
C P Conlon); Public Health 
England TB Section, Centre for 
Infectious Disease Surveillance 
and Control, Colindale, 
London, UK (M K Lalor PhD, 
L F Anderson PhD, 
Prof I Abubakar FRCP, 
H L Thomas MFPH); Public 
Health England National 
Mycobacterial Reference 
Laboratory, Queen Mary’s 
School of Medicine and 
Dentistry, London, UK 
(A Broda MRes, 
Prof F Drobniewski FRCPath); 
Thames Valley Public Health 
England Centre, Chilton, UK 
(L Saldana Ortega MSc, 
N D McCarthy (DPhil); Oxford 
Health NHS Foundation Trust, 
Oxford, UK (L Parker BA, 
S Churchill BSc, K Bennett BA); 
Scottish Mycobacteria 
Reference Laboratory, Royal 
Inﬁ rmary of Edinburgh, 
Edinburgh, UK 
(I F Laurenson FRCPath); Public 
Health England Newcastle 
Laboratory, Freeman Hospital, 
Newcastle upon Tyne, UK 
Articles
286 www.thelancet.com/respiratory   Vol 2   April 2014
(A Barrett BSc); Public Health 
England, East Midlands Centre, 
Nottingham, UK 
(P Monk FFPHM); Public Health 
England West Midlands Public 
Health Laboratory, 
Birmingham, UK 
(E G Smith FRCPath); Oxford 
National Institute for Health 
Research Biomedical Research 
Centre, John Radcliﬀ e Hospital, 
Oxford, UK (A S Walker, 
Prof D W Crook, Prof T E A Peto); 
Centre for Infectious Disease 
Epidemiology and MRC Clinical 
Trials Unit, University College 
London, London, UK 
(Prof I Abubakar); and 
Department of Infectious 
Diseases, Imperial College, 
London, UK (Prof F Drobniewski, 
A Broda)
Correspondence to:
Dr Timothy M Walker, Nuﬃ  eld 
Department of Medicine, 
University of Oxford, John 
Radcliﬀ e Hospital, Oxford 
OX3 9DU, UK
timothy.walker@ndm.ox.ac.uk
Methods
Case identiﬁ cation and sample selection
We identiﬁ ed all residents with Oxfordshire postcodes 
with an M tuberculosis culture or a clinical diagnosis of 
tuberculosis between Jan 1, 2007, and Dec 31, 2012, from 
three sources. Relevant diagnostic codes and 
microbiology results were identiﬁ ed from the Oxford 
University Hospitals (OUH) Patient Safety Server, a 
warehouse of all microbiology tests and OUH 
admissions. The OUH Trust provides all microbiology 
laboratory services, more than 99% of acute care, and 
more than 90% of specialist services in the county. 
Additionally, we reviewed all records kept by the Thames 
Valley Health Protection Unit, Chilton, UK, and local 
specialist tuberculosis nurses. All identiﬁ ed cases were 
then checked against the national Enhanced Tuberculosis 
Surveillance (ETS) database. Additional demographic 
(age, sex, social risk factors, year of UK entry, and country 
of birth), clinical (pulmonary vs non-pulmonary), and 
microbiological data (microscopy and culture results) 
were also obtained from ETS. 
At least one M tuberculosis complex culture was sought 
for each patient with microbiologically conﬁ rmed disease. 
Where possible, cultures were obtained from the OUH 
microbiology laboratory (from a frozen archive 2007–10 
and obtained prospectively from 2011 onwards). Cultures 
referred to other UK hospitals were retrieved from the 
mycobacterial reference laboratories in London, 
Birmingham, Newcastle, or Edinburgh. 
DNA preparation and sequencing
All cultures were grown in Mycobacterial Growth Indicator 
Tubes (Becton–Dickinson, Oxford, UK) containing 
modiﬁ ed Middlebrooks 7H9 liquid medium and on 
Löwenstein–Jensen agar (Media for Mycobacteria, Wales, 
UK). Mature cultures were suspended in 400 μL of 0·85% 
saline, sonicated at 35 kHz for 20 min and heated to 95°C 
for 2 h to render them non-viable. DNA was extracted and 
puriﬁ ed by use of the Fuji Quickgene kit (Kurabo Bio-
Medical, Osaka, Japan) with an added mechanical 
disruption step using the Fastprep homogeniser and 
Lysing Matrix B (MP Biomedicals, Santa Ana, CA, USA). 
All samples were processed in Oxford except where the 
Public Health England National Mycobacterial Reference 
Unit, London, processed archived samples with the cetyl 
trimethylammonium bromide method.9 
Libraries were prepared by use of Nextera kits and 
sequenced on HiSeq platforms (both Illumina, San Diego, 
CA, USA) at the Wellcome Trust Centre for Human 
Genetics, Oxford. Paired-end reads were mapped 
with Stampy (version 1.0.22)10 to the H37Rv 
(GenBank NC000962.2) reference genome as previously 
described.5 7·4% of the H37Rv genome was identiﬁ ed as 
repetitive by use of self–self BLAST and was masked. 
Variant calls in non-repetitive regions were made with 
SAMtools mpileup (version 0.1.18),11 providing they were 
supported by at least ﬁ ve reads, including one in each 
direction. Sites where minority variants represented more 
than 10% of read depth were deﬁ ned as mixed and no base 
called. Mean high-quality read-depth was 106 
(range 25–195). Within-strain read depth varied with a 
range of SD of 9–55. After update of the previous bio-
informatics mapping and ﬁ ltering processes, sites in the 
top 2·5 percentiles of read depth and within 12 nucleotides 
of another variant were included, which increased mean 
coverage from 88% to 92% of the genome without aﬀ ecting 
previously described thresholds of genetic relatedness or 
introducing false-positive variant calls.5 Consistency in 
variant calling was assessed by resequencing isolates on 
diﬀ erent ﬂ ow cells as technical replicates. Pairwise 
comparisons were used to identify only a single false-
positive variant call across 202 genomes. Short-read data 
were deposited in the European Nucleotide Archive.
Epidemiological and genomic cluster analysis
The specialist tuberculosis nurses (LP, SC, and KB), lead 
infectious diseases physician for the Oxfordshire tuber-
culosis service (CPC), and local consultant for com-
municable disease control (NDM) independently identiﬁ ed 
epidemiological linkage, deﬁ ned as shared space and time, 
masked to WGS, with discrepancies resolved by consensus. 
Assessments were according to previous national guideline-
directed cluster investi gations.12,13 Genomic clusters were 
ascertained independently of the epi demiological data, and 
were deﬁ ned where no more than 12 single-nucleotide 
polymorphisms (SNPs) separated a patient isolate from that 
of at least one other patient in the cluster. For our sequence 
Figure 1: Flow chart of sample selection
*Three laboratory contaminants were identiﬁ ed previously and three by use of whole-genome sequencing. 
390 patients identiﬁed from databases
384 cases conﬁrmed
269 culture-positive disease
256 had samples sequenced
6 excluded as likely to be laboratory contaminants*
 3 diagnosed overseas, culture status not known
 112 culture-negative disease
13 excluded because samples not 
 found or could not be cultured
9 excluded because of low-quality data
247 with sequences for analysis
For the European Nucleotide 
Archive see http://www.ebi.
ac.uk/ena/data/view/PRJEB5162
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assembling and ﬁ ltering pipeline, 12 SNPs were the 
previously deﬁ ned upper threshold of genomic relatedness 
noted within hosts and between epi demiologically related 
hosts.5 Plausible transmission networks were constructed 
for each genomic cluster, and epi demiological cluster with 
available sequence data, as previously described.5 Brieﬂ y, 
the ﬁ rst patient diagnosed in each cluster was deﬁ ned as the 
index case, with links to subsequent cases assigned ﬁ rst by 
use of any epidemiological linkage, then by genetic distance, 
and then by timing of diagnosis. Hence, the total number of 
links in each cluster is the number of patients in that cluster 
minus the index case. 
Incidence was calculated according to the postcode with 
denominator data from the Oﬃ  ce of National Statistics. 
Incidence speciﬁ c to country of birth was calculated using a 
regional denominator from the Oﬃ  ce of National Statistics 
because data for countries of birth by postcode were 
unavailable. Countries of birth with an incidence of 
tuberculosis of more than 50 cases per 100 000 population 
per year were classiﬁ ed as high incidence, and those below 
this threshold were classiﬁ ed as low incidence.14 
Phylogenetic trees were built in PhyML15 (version 3.0) using 
a generalised time reversible model and whole genomes 
under the assumption that null calls at non-variant 
positions were the same as the reference. The association 
between high-incidence versus low-incidence country of 
birth and disease characteristics or clustering by 
epidemiology or genomics was assessed with logistic 
regression in Stata (version 13.1). All analyses were adjusted 
for age and sex (availability of the other factors varied).
The Health Protection Regulations 2010 require the 
notiﬁ cation of all tuberculosis cases, and the 2003 Health 
Protection Agency Act and 2002 Statutory Instrument 1438 
provide legislative cover to undertake follow-up of notiﬁ ed 
cases of tuberculosis, including their contacts. Because 
this study was done jointly with Public Health England as 
an assessment of service delivery, including contact 
tracing, no research ethics committee application was 
required.5
Role of the funding source
The sponsors of the study had no role in the study design, 
gathering, analysis, or interpretation of data, or the writing 
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Figure 2: Country of birth of patients with tuberculosis in Oxfordshire, UK, 2007–12
Country of birth was not known for four patients. High and low incidences deﬁ ned according to WHO.14
Figure 3: Time interval between entry to the UK and diagnosis of tuberculosis
Data for year of entry to the UK were not available for 12 patients.
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of the report. MKL, LFA, IA, HLT, TEAP, and ASW had 
access to the demographic data; LSO, LP, SC, KB, NDM, 
and CPC had access to the epidemiological data; ABr, MM, 
KJJ, ICJWB, IFL, ABa, FD, EGS, ASW, TEAP, DWC, and 
CPC had access to components of the microbiological 
data; TG, APG, and CDOE had access to the WGS data. 
The corresponding author had full access to all the data 
and the ﬁ nal responsibility to submit for publication.
Results
390 Oxfordshire residents had an M tuberculosis culture or 
clinical diagnosis of tuberculosis. Six of these individuals 
were excluded because the isolates from them were 
thought to be laboratory contaminants, leaving 384 cases. 
269 patients had culture-positive disease and 112 had 
culture-negative disease, and the status of three patients 
diagnosed overseas could not be ascertained (ﬁ gure 1). 
22 (8%) of 269 isolates could not be cultured or retrieved, 
or failed WGS quality control, leaving 247 patients with 
available sequence data (ﬁ gure 1).
Median age of patients was 34 years (range 1–89), with 
255 (67%) of 380 patients born in a high-incidence country, 
103 (27%) in the UK, and 22 (6%) in another low-incidence 
country (ﬁ gure 2). The place of birth was not known for 
four patients, including one with culture-positive disease. 
For non-UK-born patients, a median 5 years (IQR 2–9) had 
elapsed since entry to the UK to tuberculosis diagnosis 
(ﬁ gure 3). The 6% of Oxfordshire’s population born in a 
high-incidence country had a tuberculosis incidence of 
109 cases per 100 000 population per year compared with 
3·5 cases per 100 000 per year for those born in a low-
incidence country (3·0 cases per 100 000 if UK born and 
7·2 per 100 000 if born in another low-incidence country). 
Three postcodes (OX3 [n=43 000], OX4 [n=62 000], and 
OX16 [n=47 000]) accounted for 20% of the Oxfordshire 
population and 233 (61%) of 383 cases for whom the 
postcode was known (ﬁ gure 4). 178 (77%) of 232 cases 
residing in these postcode areas were born in high-
incidence countries (country of origin was unknown for 
one patient) versus 77 (52%) of 148 who were living 
elsewhere (p<0·0001). 
197 (52%) of 380 evaluable patients had pulmonary 
disease (four cases had unknown site of disease), and those 
born in a low-incidence country were more likely to have 
pulmonary disease (odds ratio [OR] 1·8, 95% CI 1·2–2·9; 
p=0·009), but less likely to have culture-positive disease 
(0·6, 0·4–0·99; p=0·045; table). Social risk factors (alcohol 
or drug misuse, homelessness, or time served in prison) 
were present in 36 (14%) of 261 evaluable patients, and 
were also more prevalent in those born in low-incidence 
countries (4·4, 2·0–9·4; p<0·0001; table). There was no 
diﬀ erence in the proportion of patients with available data 
for social risk factors from high-incidence and low-
incidence countries of birth (87 [70%] of 125 and 
174 [68%] of 255 cases, respectively; p=0·81).
Epidemiological investigations had identiﬁ ed 
18 epidemiological clusters (E1–E18) with 46 patients, 
accounting for 28 potential transmission events within 
Oxfordshire over 6 years (ﬁ gure 5). All but two 
epidemiological links were between family members and 
the remaining hypothesised transmissions occurred in a 
school (E8) and in the community (E10; ﬁ gure 5). MIRU-
VNTR was introduced in 2010, but did not result in the 
identiﬁ cation of any additional epidemiological clusters. 
Although ten of 18 epidemiologically deﬁ ned clusters had 
patients born in high-incidence countries, cases born in 
low-incidence countries were more likely to be identiﬁ ed 
as part of an epidemiological cluster (OR 3·3, 95% CI 
1·4–7·8; p=0·006), independently of potentially con-
founding social risk factors (adjusted OR 3·0, 1·2–7·2; 
p=0·016; table). No signiﬁ cant diﬀ erences were noted in 
the odds of pulmonary disease, social risk factors, or 
epidemiological linkage between UK-born patients and 
those born in other low-incidence countries (p>0·45; 
appendix p 3), or in age (rank sum p=0·99; appendix p 4). 
Children (aged <18 years) were more likely to be born in 
a low-incidence country (p=0·001), and, as expected, were 
more likely to have culture-negative disease (p=0·003), and 
to be epidemiologically linked to a cluster (household or 
school; p<0·0001), although six of 13 UK-born patients 
younger than 10 years were not epidemiologically linked to 
another case (data not shown). 
Assessing pairwise nucleotide diﬀ erences in the 
247 patients with culture-conﬁ rmed disease and whole-
genome sequences, the isolates from 39 patients were 
within 12 SNPs of another isolate, forming 13 genomic 
Figure 4: Mean tuberculosis incidence in Oxfordshire (2007–12)
Map based on 383 of 384 cases: the postcode for one patient was unknown. Crown copyright and database rights 
2013 Ordnance Survey 100016969.
Mean incidence 
per 100 000 
during 2007–12 
 0–4·99
 5·00–9·99
 10·00–14·99
 15·00–19·99
 20·00–24·99
 25·00–29·99
 30·00–34·99
OX16
OX3
OX4
See Online for appendix
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clusters (G1–G13) with 26 plausible transmission events 
(ﬁ gure 5). The remaining 208 (84%) patients could not be 
genomically linked to another within the 6-year study. 
Patients born in low-incidence countries were more likely 
to be genomically linked to another case (OR 5·8, 2·7–12·4; 
p<0·0001), even after adjustment for social risk factors 
(4·8, 95% CI 1·6–14·8; p=0·006; table). For patients born 
in low-incidence countries, estimates suggested that UK-
born patients were more likely to be genomically linked to 
a cluster but numbers were too few to exclude this ﬁ nding 
being due to chance (2·0; p=0·45; appendix).
Actual diﬀ erences within genomic clusters ranged from 
zero to seven SNPs (median 1 SNP, IQR 0–2), despite a 
predeﬁ ned upper limit of 12 SNPs (ﬁ gure 6). After 
exclusion of secondary cases from each genomic cluster, 
the median pairwise SNP diﬀ erence between cases in 
Oxfordshire was 1106 (857–1715). No cluster was within 
180 SNPs of another (ﬁ gure 7). 
Within these 13 genomically deﬁ ned clusters, 
11 of 26 transmission events had been previously 
identiﬁ ed by epidemiological investigation, with none 
exceeding two SNPs. Nine of 11 transmission events were 
within a household, including four between family 
members born in high-incidence countries (G5–E3, 
G8–E5, G10–E7, and G13–E11) and one between one 
family member born in a high-incidence country and 
another in the UK (G10–E7; ﬁ gure 5). The two non-
household cases were linked within a school (G9–E8) and 
in the community (G11–E10; ﬁ gure 5). In the retrospective 
review of the 15 epidemiologically un predicted links, 
three were associated with the same homeless shelter 
(G4), one was related to time spent in the same prison 
(G4), and two had nearby addresses and shared cultural 
backgrounds (G3 and G6; appendix). No retrospective 
explanation could be found for the remaining nine links, 
including four between patients born in high-incidence 
and low-incidence countries (ﬁ gure 5). In all but one case 
(G6, two patients with smear-negative pulmonary 
disease), the clusters con taining these possible, but epi-
demiologically un conﬁ rmed transmissions involved at 
least one patient with smear-positive pulmonary tuber-
culosis. Of the seven clusters that had household 
transmissions, ﬁ ve also had genomic links to non-
household members not identiﬁ ed on contact tracing 
(ﬁ gure 5; appendix).
We noted 17 epidemiologically identiﬁ ed but geno mically 
unconﬁ rmed transmission events. Of these, three were 
genomically unrelated (22, 721, and 1746 SNPs), 12 could 
not be assessed because of culture-negative disease, and 
two because of sample preparation problems (ﬁ gure 5). 
The patient who was genomically separated from family 
members by 22 SNPs migrated to the UK 4 years after the 
other cases were diagnosed, making direct transmission 
very unlikely. However, a distance of 22 SNPs is consistent 
with a dominant circulating clone in the family’s region of 
origin as a common source.5 A similar explanation might 
apply to two patients separated by 17 SNPs, born in 
diﬀ erent countries in east Africa but not epidemiologically 
linked (ﬁ gure 5). 
Using WGS with a 12 SNP threshold as the gold 
standard, epidemiological investigation had a sensitivity of 
0·42 (95% CI 0·23–0·63) and speciﬁ city of 0·99 (0·96–1·0) 
for detection of transmissions. The sensitivity of epi-
demiological investigation was 0·46 (0·25–0·67) with 
application of a stricter relatedness threshold of ﬁ ve SNPs 
(speciﬁ city 0·99 [0·96–1·0]), and 0·59 (0·33–0·82) with a 
one SNP threshold (0·98 [0·96–0·99]). 
All Oxfordshire isolates were compared with previously 
reported sequences from 254 patients within epidemi-
ologically identiﬁ ed clusters in the Midlands.5 One 
Oxfordshire patient with M bovis was within two SNPs of 
the nearest patient in a Midlands Mycobacterium bovis 
Patients with 
data available
Patients born in low-
incidence countries
Patients born in high-
incidence countries
Odds ratio* 
(95% CI)
p value
Pulmonary disease 380 (99%) 78/125 (62%) 119/254 (47%) 1·8 (1·2–2·9) 0·009
Social risk factor 261 (68%) 23/87 (26%) 13/174 (7%) 4·4 (2·0–9·4) <0·0001
Culture positive disease 377 (98%) 81/125 (65%) 186/252 (74%) 0·6 (0·4–0·99) 0·045
Paediatric disease (age <18 years) 384 (100%) 16/125 (13%) 8/255 (3%) 4·8 (2·0–11·5) 0·001
Epidemiological cluster 
All evaluable patients 384 (100%) 25/125 (20%) 21/255 (8%) 3·3 (1·7–6·3) <0·0001
Social risk factor data available (not adjusted for social risk factors) 261 (68%) 14/87 (16%) 11/174 (6%) 3·3 (1·4–7·8) 0·006
Social risk factor data available (adjusted for social risk factors) 261 (68%) 14/87 (16%) 11/174 (6%) 3·0 (1·2–7·2) 0·016
Whole-genome-sequencing cluster
All evaluable patients 247 (64%) 24/74 (32%) 15/172 (9%) 5·8 (2·7–12·4) <0·0001
Social risk factor data available (not adjusted for social risk factors) 164 (43%) 14/53 (26%) 8/117 (7%) 6·4 (2·2–18·8) 0·001
Social risk factor data available (adjusted for social risk factors) 164 (43%) 14/53 (26%) 8/117 (7%) 4·8 (1·6–14·8) 0·006
Data are number (%) or n/N (%), unless otherwise indicated. Denominators were the numbers of patients for whom data were available for the variables that were being compared. *For low-incidence countries 
versus high-incidence countries of birth and calculated with multivariable logistic regression, adjusted for age and sex (just sex for children), and for social risk factors where indicated. Social risk factors are at 
least one of the following: homelessness, drug or alcohol misuse, or time spent in prison.
Table: Associations between country of birth and tuberculosis characteristics and epidemiological or genomic clustering
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outbreak, and one cluster (G2) of four Oxfordshire patients 
was within nine SNPs of an M tuberculosis cluster in the 
Midlands (clusters 11 and ﬁ ve, respectively in Walker and 
colleagues5). No epidemiological links spanning these 
geographical boundaries were previously suspected in 
either case, although patients in the clusters had similar 
social risk factors. 
Discussion
Over 6 years, 2007–12, we noted 26 (11%) of 246 genomically 
deﬁ ned links between evaluable cases. Although more 
patients with tuberculosis were born in high-incidence 
than in low-incidence countries, those born in low-
incidence countries, predominantly the UK, were more 
likely to be part of a genomically deﬁ ned cluster (panel). 
Of the 384 cases identiﬁ ed, 269 had microbiologically 
conﬁ rmed disease and of these 247 had isolates that 
were sequenced. Pairwise SNP distances were used to Figure 6: Minimum genetic distance between isolates
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Figure 5: All cases in Oxfordshire, UK, (2007–12) by incidence in country of birth, and by epidemiological and genomic clustering
Patients born in low-incidence countries are on the left and those born in high-incidence countries are on the right of the ﬁ gure. Four patients whose country of birth 
was not known are at the bottom centre of the ﬁ gure. Each shape (triangle or circle) represents a patient. Epidemiological clusters (E1–18) are circled in black and 
genetic links, shown as networks with edges representing the genetic distance, are circled in red. Edges in networks are red for distances within 12 SNPs. Ge netic links 
of interest but greater than 12 SNPs are indicated by black dashed lines, representing the SNP distances. Patients in WGS clusters who are zero SNPs apart are 
indicated by shapes that abut each other, whereas distances of at least 1 SNP are quantiﬁ ed by the number of red lines (separated by small black nodes if >1 SNP) 
between patients. Epidemiological or WGS clusters that include patients born in low-incidence countries and patients born in high-incidence countries cross the 
central vertical line. SNP=single-nucleotide polymorphism. WGS=whole-genome sequencing.
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identify plausible transmissions, using a threshold of 
12 SNPs as indication of the maximum pathogen genetic 
diversity previously noted within hosts and between epi-
demiologically related hosts.5 A bimodal picture emerged 
with 24 genomic distances spanning zero to four SNPs, 
218 longer than 30 SNPs, and only four between ﬁ ve and 
30 SNPs, in keeping with previous ﬁ ndings that most 
patients in a transmission chain are within ﬁ ve SNPs of 
another patient.5,19–21 
Although 67% of patients were born in a high-incidence 
country, these patients were less likely to have pulmonary 
disease and more likely to be genetically independent of 
other cases than were patients born in low-incidence 
countries. This result was also noted in previous studies 
based on lower resolution ﬁ ngerprinting methods, 
although these also suggested an overall rate of trans-
mission twice that identiﬁ ed here.17,18,22 Our ﬁ ndings 
suggest that most patients born in high-incidence 
countries reactivate latent infection acquired abroad and 
are not involved in local onward transmission. Unrestricted 
access to diagnostic and treatment services through the 
UK National Health Service (NHS) is likely to have 
contributed to this public health success. As previously 
noted in other European settings, most migrants to the UK 
were diag nosed within 5 years of arrival.23 The patchwork 
nature of new-entrant screening in the UK (individual data 
not available)24 stresses the importance of unrestricted 
access to health care in the early post-migration period in 
particular. Although health care is freely available to all UK 
residents, the services seem to have been less eﬀ ective in 
controlling disease in patients born in low-incidence 
countries. Possible explanations might be that the excess 
of social risk factors in these patients led to inadequate 
health-care-seeking behaviour, or that health-care pro-
fessionals investigate other diagnoses before diagnosing 
tuberculosis in this population. Both out comes could lead 
to increased periods of infectivity and hence greater 
onward trans mission.
There are several limitations to this study. Like all typing 
methods, WGS cannot be used to ascertain the source of 
culture-negative cases. Similarly, we were unable to assess 
the amount of transmission leading to latent tuberculosis, 
as data for interferon-γ release assay results could not be 
linked back to speciﬁ c contact tracing investigations with 
conﬁ dence. However, 45 (73%) of 62 patients with sputum-
smear-positive disease could not be genomically linked to 
any other case of active disease in Oxfordshire between 
2007–12, which supports the intervention programme 
being fairly successful. MIRU-VNTR typing was only 
introduced routinely in the UK in 2010, and between 
2010–12 MIRU-VNTR cluster investigations were 
recommended if clusters reached a deﬁ ned threshold size 
or contained cases with deﬁ ned risk factors. In the study 
population, no additional epidemiological links were 
identiﬁ ed when cluster investigation was done with this 
approach. Because the superior resolution of WGS has 
already been shown,5–7 we did not attempt a further 
comparison.  Were the UK-based social networks of recent 
migrants to span larger geographical distances than were 
those of long-term residents, then recent migrants might 
more frequently be linked to transregional rather than 
regional outbreaks. However, the two genomic links we 
made to the Midlands involved patients born in low-
incidence, not high-incidence, countries.
Panel: Research in context
Systematic review
We searched PubMed with the key words “tuberculosis”, and “whole genome sequencing”, 
“population based”, “transmission”, or “epidemiology” for population-based 
molecular-epidemiology studies of tuberculosis published in English before October, 2013. 
Studies of typing with restriction fragment length polymorphism (RFLP) have been 
reviewed by Houben and Glynn,16 whereas Allix-Beguec17 and Roetzer18 investigated 
unselected populations by use of the more contemporary typing method mycobacterial 
interspersed repetitive unit variable number tandem repeat. More recent studies of the 
genetic diversity of Mycobacterium tuberculosis within and between hosts in outbreak 
settings have shown superior resolution of whole-genome sequencing (WGS) over the 
previous ﬁ ngerprinting methods.5–7,19–21 However, to our knowledge this is the ﬁ rst 
population-based study in which the potential of WGS is used to more accurately quantify 
transmission of tuberculosis within a deﬁ ned locality over a ﬁ xed period.
Interpretation
In our study, metrics of genetic relatedness derived from recent WGS-based tuberculosis 
transmission studies were applied to an unselected population for the ﬁ rst time. Because 
inferences about recent transmission can be made from WGS data with greater certainty 
than has hitherto been possible using molecular ﬁ ngerprinting techniques, we can describe 
the local epidemiology of tuberculosis with unprecedented clarity. This approach has enabled 
us to assess the eﬀ ectiveness of current tuberculosis control measures and to provide data to 
inform the design of future public health interventions. Because patients born in low-
incidence countries (mainly the UK) are more likely to be involved in recent transmission 
chains than are patients born in high-incidence countries, we emphasise the need for 
systematic new entrant screening and continued free access to health care for all.
Figure 7: Phylogenetic relations between whole-genome-sequencing clusters
Maximum likelihood tree of 13 clusters as ascertained with whole genome sequencing are represented by red 
circles. SNP distances are annotated on the branches. SNP=single-nucleotide polymorphism.
90
75
329
309
304
266
185
232
108
147 195
94
146144
1191
Articles
292 www.thelancet.com/respiratory   Vol 2   April 2014
Our study has several advantages for the future use of 
WGS. We identiﬁ ed 15 plausible but previously un-
recognised transmissions within Oxfordshire. Several of 
these additional transmissions were from epi demiologically 
identiﬁ ed household outbreaks to other non-household 
members. Had these links been identiﬁ ed in near-to-real-
time, more intensive investigation might have shown other 
important routes of transmission, possibly resulting in 
public health action.25 By genomically linking patients in 
Oxfordshire and the Midlands we also show the potential 
for identifying previously unrecognised transmission 
across public health regions. This technique is restricted 
only by the size of the database for comparison, and not by 
geographical boundaries, so it could be applied to extend 
future contact investigations across larger regions.
In this low-incidence setting, the burden of disease was 
largely sustained by cases infected either outside of the 
county or the period of study, and onward transmission 
within the region was associated with birth in a low-
incidence rather than a high-incidence setting. Measures 
targeted at disease control would therefore best be focused 
on screening new entrants from high-incidence settings for 
active and latent disease and on improving diagnosis in and 
access to primary health care for the hard-to-reach groups. 
In view of these ﬁ ndings, suggested policy inter ven tions 
aimed at restricting access to NHS care for new en trants, 
many born in high-incidence countries, raise con cerns that 
disease control could be jeopardised. Eﬀ ective investi gation, 
diagnosis, and treatment must remain the priorities. 
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